Old Web
Oral bioavailability of dabigatran etexilate (Pradaxa®) after co-medication with verapamil in healthy subjects
2013
Aim
To investigate the effect of the P-glycoprotein inhibitor verapamil on the pharmacokinetics and pharmacodynamics of dabigatran etexilate (DE).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
19
References
122
Citations
NaN
KQI